Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Children's Hospital of Philadelphia at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Children's Hospital of Philadelphia brings 46 presentations to ASH 2026 in New Orleans, and exhibits at Booth 2221. Its research centres on gene editing and CAR T cells for pediatric blood disorders. It covers base editing for pyruvate kinase deficiency, genome editing for hemophilia A and CAR T therapy for refractory childhood leukemia.

OrganizationASH 2026 Attendance
Hospitals & cancer centres
Pediatric hospital and research institute in Philadelphia, with major programs in pediatric hematology, sickle cell disease and cell and gene therapy.
Booth
Exhibiting at Booth 2221
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
7:00pm–10:00pm
Overcoming the Challenges of Managing Adolescents and Young Adults With Ph-Negative Acute Lymphoblastic Leukemia
Pediatric-style regimens, asparaginase, immunotherapy, and CAR-T for teens and young adults with acute lymphoblastic leukemia, plus their psychosocial needs.
Leukemias
Talk
Sat Dec 12
2:00pm–3:15pm
Lipid Nanoparticle (LNP) Delivery to Hematopoietic Stem Cells in Vivo
Delivering mRNA and gene editors to blood stem cells inside the body with lipid nanoparticles, including editing before birth for inherited blood diseases.
Cell & gene
Talk
Sat Dec 12
2:00pm–3:15pm
Unmet Needs in Transfusion Medicine: Alloimmunization, Rare Blood Types, and the Case for Lab-Grown Red Cells
Patients with rare blood types or antibodies against donor red cells struggle to find matches, and engineered lab-grown cells could supply tailored units.
Red cells
Talk
Sat Dec 12
4:00pm–5:15pm
Heparin-Induced Thrombocytopenia (HIT): How Heparin Sparks Thrombosis
How the blood thinner heparin binds a platelet protein and provokes antibodies that drop platelet counts and paradoxically cause dangerous clots.
Clotting
Session
Mon Dec 14
10:30am–11:45am
Unlocking Blood Disorders: Targeting Genetics to Identify Early Phenotypes
Genomic tools and better disease models are changing how inherited blood disorders in children are found, understood, and managed.
Clotting · Blood biology
Session
Mon Dec 14
4:30pm–5:45pm
Iron Homeostasis Across the Lifespan in Health and Disease
Iron balance from fetal life to old age, what goes wrong in deficiency and overload, and the pathways being targeted to treat iron-related disorders.
Red cells
Session
Mon Dec 14
4:30pm–6:00pm
The Future of Clinical Endpoints in Sickle Cell Disease
Better sickle cell disease trial endpoints than pain-crisis counts, such as biomarkers, combined measures, and patient-reported outcomes reflecting daily burden.
Red cells

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Children's Hospital of Philadelphia

Tell us what you sell and we’ll find the people at Children's Hospital of Philadelphia most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction